Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

(2015) Raymond Hupperts et al.   Multiple Sclerosis Journal

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

(2015) Raymond Hupperts et al.   Multiple Sclerosis Journal

Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies

(2014) Mariko Kita et al.   CLINICAL THERAPEUTICS

Placebo Effects in a Multiple Sclerosis Spasticity Enriched Clinical Trial with the Oromucosal Cannabinoid Spray (THC/CBD): Dimension and Possible Causes

(2014) Vincenzo Di Marzo et al.   CNS Neuroscience & Therapeutics

Impact of Mobility Impairment on Indirect Costs and Health-Related Quality of Life in Multiple Sclerosis

(2013) Craig I. Coleman et al.   PLoS One

How People with Multiple Sclerosis Rate Their Quality of Life: An EQ-5D Survey via the UK MS Register

(2013) Kerina H. Jones et al.   PLoS One

Social and economic burden of walking and mobility problems in multiple sclerosis

(2012) James Pike et al.   BMC Neurology

The impact of slower walking speed on activities of daily living in patients with multiple sclerosis

(2012) M. Yildiz   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis

(2012) Arun V Krishnan et al.   Multiple Sclerosis Journal

Health-Related Quality of Life Is Reduced in Multiple Sclerosis Patients Whose Walking Speed Declines over Time (P07.096)

(2012) A. Krishnan et al.   NEUROLOGY

Relationship between Timed 25-Foot Walk Walking Speed and Health-Related Quality of Life in AFFIRM and SENTINEL (P07.097)

(2012) C. Polman et al.   NEUROLOGY

Work Productivity in Relapsing Multiple Sclerosis: Associations with Disability, Depression, Fatigue, Anxiety, Cognition, and Health-Related Quality of Life

(2012) Bonnie I. Glanz et al.   VALUE IN HEALTH

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

(2010) Andrew D. Goodman et al.   ANNALS OF NEUROLOGY

Multiple sclerosis and mobility-related assistive technology: Systematic review of literature

(2010) Ana Souza et al.   JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT

Contribution of impaired mobility to patient burden in multiple sclerosis

(2009) Matthew H. Sutliff   CURRENT MEDICAL RESEARCH AND OPINION

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

(2009) Andrew D Goodman et al.   LANCET

The development of patient-reported outcome indices for multiple sclerosis (PRIMUS)

(2009) LC Doward et al.   Multiple Sclerosis Journal

Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable

(2008) C Heesen et al.   Multiple Sclerosis Journal